Plasmids encoding granulocyte-macrophage colony-stimulating factor and CD154 enhance the immune response to genetic vaccines.

Plasmids encoding granulocyte-macrophage colony-stimulating factor and CD154 enhance the immune response to genetic vaccines.
复制标题

编码粒细胞-巨噬细胞集落刺激因子和 CD154 的质粒可增强对基因疫苗的免疫反应。

DOI:
10.1016/s0264-410x(00)00382-0
复制
发表时间:
2001
期刊:
影响因子:
5.5
通讯作者:
Kipps,TJ
Kipps,TJ
中科院分区:
医学3区
文献类型:
--
作者:
Burger,JA;Mendoza,RB;Kipps,TJ

文献摘要

参考文献

被引文献

相似文献

我们研究了编码粒细胞-巨噬细胞集落刺激因子(pGM-CSF)或CD 40-配体(pCD 40 L)的质粒是否可以改变对共注射质粒DNA编码的抗原的免疫应答。为此,我们使用由质粒pLacZ编码的土方嗜酸乳杆菌β半乳糖苷酶(β-gal)作为抗原。我们发现,皮内共注射pLacZ与pGM-CSF和pCD 40 L两者与单独注射pLacZ相比将抗β-gal IgG应答增强约两个数量级。与pLacZ和pGM-CSF或pCD 40 L共注射的动物相比,pGM-CSF和pCD 40 L与pLacZ共注射显著增强了抗原特异性IgG,特别是IgG 2a。我们发现,pGM-CSF和pCD 40 L与pLacZ的共注射增强了β-gal特异性细胞毒性T细胞的产生,并且允许从与表达β-gal的刺激细胞共培养的脾细胞显著扩增CD 8 +T细胞。pGM-CSF或pCD 40 L诱导的免疫刺激作用需要将这些质粒注射到接受pLacZ的同一位点。“致敏”实验(其中注射部位预先注射任一种质粒佐剂)显示pGM-CSF而不是pCD 40 L可增强随后施用的质粒抗原诱导的抗β-gal免疫应答。我们得出结论,编码GM-CSF和CD 154的质粒是特别有效的遗传佐剂,当一起使用,以增强体液和细胞免疫应答的质粒编码的抗原。
We examined whether plasmids encoding granulocyte–macrophage colony-stimulating factor (pGM-CSF) or CD40-ligand (pCD40L) could modify the immune response to antigen encoded by co-injected plasmid DNA. For this we used as antigen Escherichiacoli β galactosidase (β-gal), encoded by the plasmid pLacZ. We found that intradermal co-injection of pLacZ with both pGM-CSF and pCD40L enhanced the anti-β-gal IgG response by approximately two orders of magnitude compared to injections of pLacZ alone. Co-injection of both pGM-CSF and pCD40L with pLacZ significantly enhanced antigen-specific IgG, and in particular IgG2a, over that of animals co-injected with pLacZ and either pGM-CSF or pCD40L. We found that co-injection of pGM-CSF and pCD40L with pLacZ enhanced the generation of β-gal-specific cytotoxic T cells, and allowed for a significant expansion of CD8+T cells from splenocytes co-cultured with β-gal expressing stimulator cells. The immunostimulatory effects induced by pGM-CSF or pCD40L required injection of these plasmids to the same site that received pLacZ. ‘Priming’ experiments, where the site of injection was pre-injected with either plasmid adjuvant, showed that pGM-CSF, but not pCD40L, could enhance the anti-β-gal immune response induced by subsequently administered plasmid antigen. We conclude that plasmids encoding GM-CSF and CD154 are particularly effective genetic adjuvants when used together to enhance the humoral and cellular immune response to a plasmid-encoded antigen.
DOI: 10.1016/s0264-410x(97)88856-1
发表时间: 1997-12-01
期刊: VACCINE
影响因子: 5.5
作者:
Sin, JI;Sung, JH;Sung, YC
通讯作者: Sung, YC
免疫刺激性 CpG 寡脱氧核苷酸可增强对涉及粒细胞-巨噬细胞集落刺激因子的疫苗策略的免疫反应。
DOI: 10.1182/blood.v92.10.3730.422k20_3730_3736
发表时间: 1998
期刊: Blood
影响因子: 20.3
作者:
Hsin;Sally E. Newbrough;Sudershan K. Bhatia;C. Dahle;A. Krieg;G. Weiner
通讯作者: G. Weiner
具有治疗有用基因的新鲜切除的肿瘤外植体的快速腺病毒转导为结直肠癌的基因免疫治疗提供了理论依据
DOI: 10.1038/sj.gt.3300690
发表时间: 1998
期刊: Gene Therapy
影响因子: 5.1
作者:
RM Diaz;S. Todryk;H. Chong;I. Hart;K. Sikora;S. Dorudi;R. Vile
通讯作者: R. Vile
DOI: 10.4049/jimmunol.161.5.2094
发表时间: 1998-09
影响因子: 4.4
作者:
M. Mackey;Jason R. Gunn;C. Maliszewski;Hitoshi Kikutani;R. Noelle;Richard J. Barth
通讯作者: M. Mackey;Jason R. Gunn;C. Maliszewski;Hitoshi Kikutani;R. Noelle;Richard J. Barth
DOI: 10.1182/blood.v91.1.222.222_222_230
发表时间: 1998-01-01
期刊: BLOOD
影响因子: 20.3
作者:
Dunussi-Joannopoulos, K;Dranoff, G;Croop, JM
通讯作者: Croop, JM